4569 — Kyorin Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual balance sheet for Kyorin Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	32,918	30,844	27,494	19,394	13,985
Net Total Accounts Receivable
Net Total Receivables	47,409	40,409	41,636	47,250	47,698
Total Inventory
Total Other Current Assets
Total Current Assets	117,058	114,027	116,376	119,030	119,310
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22,721	23,896	24,334	25,834	28,950
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	171,160	167,126	171,924	176,045	177,679
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	31,328	27,407	32,182	34,983	45,491
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	48,450	42,465	47,417	50,584	46,896
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	122,710	124,661	124,507	125,461	130,783
Total Liabilities & Shareholders' Equity	171,160	167,126	171,924	176,045	177,679
Total Common Shares Outstanding